Conformis, Inc. announced that the first procedure with the company's new Actera™ Hip System has been performed. The new system is currently rolling out to select sites across the U.S., and the company anticipates the full commercial launch of Actera in mid-2023. Actera will feature several personalization options for surgeons to choose what best fits their patients, even for complex anatomies.

The new Actera Hip System uses the cutting-edge tri-taper stem design, which features a range of sizes and angles derived from the company's deep data analytics of its large patient database. This cementless hip stem component features a proximally coated titanium spray with a hydroxyapatite layer to encourage initial and long-term fixation. Actera is available in variable collar lengths to avoid the overhang or stem subsidence that can occur when using implants with fixed collar lengths.

In addition, the hip system has two head-center options in each size, enabling a more intuitive intraoperative experience. Most significantly, this is a major building block for the future. Once Actera's tri-taper stem design is combined with Conformis' proprietary three-dimensional, data-driven personalized hip planning software, surgeons will be able to choose, pre-operatively, the best fit implant construct for their patients' needs and their choice in surgical technique.

The company believes this will result in a more efficient and streamlined operating room experience, a less invasive procedure, and a more stable fit for initial and long-term fixation.